On the left the prognosis from June 17th 2011 and on the right where we are today. The stock dropped some $40 after completing the B-wave. One would be forgiven for believing that this stock might be counter-cyclical as, presumable, the consumption of aspirin is inversely related to the stock markets. Not so. We are most probable in wave 4 of C and should drop at least to $30 or so, which also happens to be the top of wave 1 up in the (extended) 5th wave to the top.